Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor

International Journal of Infectious Diseases

Volumn 11, Issue 6, 2007, Pages 549-550

  Williams, John ^a   Lim, Robert ^a   Tambyah, Paul ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; BEVACIZUMAB; FLUOROURACIL; ITRACONAZOLE; OXALIPLATIN; VASCULOTROPIN INHIBITOR;

ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANCER CHEMOTHERAPY; CASE REPORT; COLON CANCER; COUGHING; DRUG RESPONSE; DRUG TOLERABILITY; FEVER; HUMAN; LETTER; LUNG BIOPSY; MALE; NEUTROPENIA; NEUTROPHIL COUNT;

AMPHOTERICIN B; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED;

EID: 35448984601     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.01.007     Document Type: Letter

References (9)

1. Denning D.W., and Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Inf Dis 12 (1990) 1147-1201
2. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
3. Kumagai H., Someno T., Dobashi K., Isshiki K., Ishizuka M., and Ikeda D. ICM0301s, New angiogenesis inhibitors from Aspergillus sp. F-1491. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 57 (2004) 97-103
4. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 (1990) 555-557
5. Udagawa T., Yuan J., Panigrahy D., Chang Y.H., Shah J., and D'Amato R.J. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther 294 (2000) 421-427
6. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
7. Xiong M., Elson G., Legarda D., and Leibovich S.J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153 (1998) 587-598
8. Inoue K., Matsuyama W., Hashiguchi T., Wakimoto J., Hirotsu Y., Kawabata M., et al. Expression of vascular endothelial growth factor in pulmonary aspergilloma. Intern Med 40 (2001) 1195-1199
9. Johnson D.H., Fehrenbacher L., Novotny W.F., Herbst R.S., Nemunaitis J.J., Jablons D.M., et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22 (2004) 2184-2191